Shares of Accelerant Holdings (NYSE:ARX - Get Free Report) have been given a consensus recommendation of "Hold" by the twelve brokerages that are currently covering the stock, MarketBeat.com reports. Two investment analysts have rated the stock with a sell recommendation, seven have issued a hold recommendation and three have issued a buy recommendation on the company. The average twelve-month target price among brokers that have updated their coverage on the stock in the last year is $17.98.
A number of brokerages recently commented on ARX. Weiss Ratings raised Accelerant from a "sell (d)" rating to a "sell (d+)" rating in a research report on Friday, November 13th. Raymond James Financial lowered Accelerant from a "market perform" rating to an "underperform" rating in a report on Wednesday, September 23rd. Royal Bank Of Canada cut Accelerant from a "moderate buy" rating to a "hold" rating and set a $20.25 price objective for the company. in a research note on Friday, August 14th. Citigroup downgraded Accelerant from an "outperform" rating to a "market perform" rating in a report on Thursday, August 13th. Finally, TD Cowen lowered Accelerant from a "buy" rating to a "hold" rating and lowered their target price for the stock from $30.00 to $20.25 in a research report on Wednesday, September 30th.
Get Our Latest Stock Analysis on ARX
Insider Buying and Selling at Accelerant
In other Accelerant news, Director Nancy Hasley sold 54,508 shares of Accelerant stock in a transaction dated Monday, November 16th. The stock was sold at an average price of $19.89, for a total transaction of $1,084,164.12. Following the completion of the transaction, the director owned 1,017,326 shares in the company, valued at approximately $20,234,614.14. The trade was a 5.09% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 66.59% of the stock is owned by corporate insiders.
Institutional Investors Weigh In On Accelerant
Several institutional investors have recently bought and sold shares of ARX. Glazer Capital LLC purchased a new position in Accelerant during the 3rd quarter worth $152,908,000. Deer Park Road Corp purchased a new stake in shares of Accelerant in the third quarter valued at about $90,645,000. Gabelli Funds LLC purchased a new stake in shares of Accelerant in the third quarter valued at about $12,419,000. GABELLI & Co INVESTMENT ADVISERS INC. bought a new position in shares of Accelerant during the third quarter valued at about $9,152,000. Finally, Alberta Investment Management Corp bought a new position in shares of Accelerant during the third quarter valued at about $6,906,000.
Accelerant Stock Down 0.1%
Shares of Accelerant stock opened at $19.88 on Friday. The stock's 50-day moving average is $19.80 and its 200 day moving average is $15.39. Accelerant has a one year low of $9.18 and a one year high of $19.92. The firm has a market cap of $4.32 billion, a price-to-earnings ratio of 70.98 and a beta of 0.08. The company has a debt-to-equity ratio of 0.16, a current ratio of 1.61 and a quick ratio of 1.61.
Accelerant (NYSE:ARX - Get Free Report) last released its quarterly earnings data on Thursday, November 12th. The company reported $0.18 earnings per share for the quarter, missing the consensus estimate of $0.20 by ($0.02). Accelerant had a net margin of 5.24% and a return on equity of 26.71%. The company had revenue of $280.20 million during the quarter. Equities research analysts anticipate that Accelerant will post 0.88 EPS for the current year.
Accelerant Company Profile
(
Get Free Report)
Accelerant is a data-driven risk exchange focused on the specialty insurance market. Its platform connects independent specialty insurance underwriters, including managing general agents, with insurance capacity providers seeking access to specialized risks. The company provides technology, data and analytics tools to support underwriting and help its members evaluate and manage insurance portfolios. Through the exchange, underwriters can access capacity, while insurers and other risk-bearing partners can connect with specialist underwriting expertise.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Accelerant, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Accelerant wasn't on the list.
While Accelerant currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.